The exploding marijuana industry is rife with indirect plays that could be safer bets on growth because they’re involved in non-cannabis niches as well. One such stock is Psychemedics (NSDQ: PMD), a drug-testing firm. Unlike many direct marijuana opportunities, this firm is generating real revenue and profits. The question is… Read More

Uranium is one of the most specialized chemical elements on the planet. Its commercial use is limited to fueling power plants and making weapons. The best uranium stocks to buy now are those that have an inside track on those markets. The nuclear energy sector has undergone considerable change during… Read More

The marijuana boom is one of the greatest investment frenzies we’ve seen since the dot.com bubble of the late 1990s. Will the “green rush” end the same way, with pain for investors? You can make a lot of money in cannabis, as long as you remain prudent in your stock… Read More

As in the horror movie "Bird Box," investors are blindfolded regarding economic data, due to the government shutdown. How to trade when the future is obscured. Read More

Some of the best marijuana stocks are indirect plays on the industry. If pot goes bust, these firms can still rely on other core operations. GreenGro Technologies (OTC: GRNH) is an indirect marijuana play getting investor attention these days. It’s the sort of company we call “cannabis adjacent.” These are… Read More

The movement of energy prices can exert a profound effect on your overall portfolio. Here's what we see for the energy sector in 2019. Read More

Medicine Man Technologies (OTC: MDCL) belongs to a fast-growing marijuana industry niche: consulting and infrastructure services. Medicine Man is not a marijuana producer. The chattering class on Wall Street is infatuated with cannabis stocks. But with Medicine Man, we must raise several caveats. Not only is this a marijuana play,… Read More

The marijuana “green rush” is one of the biggest investment opportunities you can find. But you need to be selective. In this article, we scrutinize AmeriCann (OTC: ACAN) and its prospects for 2019. AmeriCann is a penny stock that has no real revenue or earnings, and plenty of debt. As… Read More

Gilead has seen its stock price slide in recent years as sales of its hepatitis c drugs are falling sharply. Are better days ahead? Read More

Tata Motors (NYSE: TTM) is making good on its promise to cut costs to improve profitability. Yesterday, Tata Motors announced that it is eliminating 4,500 jobs in its Jaguar Land Rover division in Europe. Its share price jumped 1% on the news, trading… Read More